APPLICATION OF COMBINED DRUG OF RECOMBINANT FOLLICULE-STIMULATING HORMONE/LUTEINIZING HORMONE IN PROGRAMS OF ASSISTED REPRODUCTIVE TECHNOLOGIES

APPLICATION OF COMBINED DRUG OF RECOMBINANT FOLLICULE-STIMULATING HORMONE/LUTEINIZING HORMONE IN PROGRAMS OF ASSISTED REPRODUCTIVE TECHNOLOGIES

Infertility treatment using assisted reproductive technologies in the majority of cases involving the use of various ovarian stimulation protocols to obtain the optimal number of oocytes and embryos.The use of analogues of gonadotropin-releasing hormone in ART programs prevents the synthesis of endo...

Full description

Bibliographic Details
Main Authors:	A. G. Syrkasheva, E. O. Ibragimova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	infertility assisted reproductive technologies controlled ovarian stimulation gonadotropin-releasing hormone
Online Access:	https://www.med-sovet.pro/jour/article/view/1436

Similar Items

The role of the growth hormone in assisted reproductive technologies cycles
by: Andrey Y Romanov, et al.
Published: (2019-08-01)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
by: Behnaz Khani Rabati, et al.
Published: (2012-01-01)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
by: Gottumukkala Achyuta Rama Raju, et al.
Published: (2013-01-01)

Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
by: Amar Ramachandran, et al.
Published: (2014-01-01)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
by: Daniele Santi, et al.
Published: (2017-06-01)

Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?
by: Neeta Singh, et al.
Published: (2021-01-01)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
by: Daniele Santi, et al.
Published: (2018-03-01)

Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty
by: Dong-Min Lee, et al.
Published: (2019-03-01)

Effects of Luteinizing Hormone Supplementation on Ovarian Response and Assisted Reproductive Technology Outcomes in Antagonist In vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-analysis
by: Lei Chen, et al.
Published: (2019-01-01)

Advances in the Regulation of Mammalian Follicle-Stimulating Hormone Secretion
by: Hao-Qi Wang, et al.
Published: (2021-04-01)

Reproductive neuroendocrinology of mammalian gonadotropin‐inhibitory hormone
by: Takayoshi Ubuka, et al.
Published: (2019-07-01)

A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
by: Michiko Hamada, et al.
Published: (2022-01-01)

Basal level of luteinizing hormone as a key marker of the idiopathic central hypogonadism in women
by: A. S. Loktionova, et al.
Published: (2020-12-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a review of literature
by: Maryam Eftekhar, et al.
Published: (2021-10-01)

The İmpact of gonadotropin type on controlled ovarian stimulation and İntrauterine İnsemination cycle outcomes
by: Ozge Senem Yucel Cicek, et al.
Published: (2022-01-01)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019-03-01)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
by: Shikha Jain, et al.
Published: (2016-01-01)

Addition of a carboxy-terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female mice
by: Chirine Toufaily, et al.
Published: (2021-12-01)

The use of gonadotropin-releasing hormone antagonist in women undergoing intrauterine insemination
by: M Yousef Elsemary, et al.
Published: (2019-01-01)

The Effect of Regular Exercise on Reproductive Hormones in Male Athletes
by: Yıldırım Kayacan, et al.
Published: (2017-09-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Analysis of the clinical efficiency of human menopausal gonadotropins in the assisted reproductive technology program
by: Yu. A. Drapkina, et al.
Published: (2021-10-01)

Real-world practices of hormone monitoring during ovarian stimulation in assisted reproductive technology: a global online survey
by: Noemie Sachs-Guedj, et al.
Published: (2023-11-01)

The negative impact of levothyroxine treatment on urinary luteinizing hormone measurements in pediatric patients with thyroid disease
by: And Demir, et al.
Published: (2023-12-01)

ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01)

Review: Gonadotropin-inhibitory hormone action in the brain and pituitary
by: Takayoshi eUbuka, et al.
Published: (2012-11-01)

Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy?
by: Monica Lispi, et al.
Published: (2023-05-01)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
by: Farrah L. Saleh, M.D., et al.
Published: (2023-06-01)

Impulsive time series modeling with application to luteinizing hormone data
by: Håkan Runvik, et al.
Published: (2022-11-01)

Inducible Kiss1 knockdown in the hypothalamic arcuate nucleus suppressed pulsatile secretion of luteinizing hormone in male mice
by: Shiori MINABE, et al.
Published: (2020-04-01)

Effect of follicle-stimulating hormone and luteinizing hormone levels on egg-laying frequency in hens
by: Ragil Angga Prastiya, et al.
Published: (2022-12-01)

Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study
by: Mei Dong, et al.
Published: (2021-11-01)

Seasonal Related Multifactorial Control of Pituitary Gonadotropin and Growth Hormone in Female Goldfish: Influences of Neuropeptides and Thyroid Hormone
by: Yifei Ma, et al.
Published: (2020-04-01)

Effects of a Recombinant Gonadotropin-Releasing Hormone Vaccine on Reproductive Function in Adult Male ICR Mice
by: Ai-Mei Chang, et al.
Published: (2021-07-01)

Association of follicular fluid volume with membrane stretchability of human metaphase II oocytes following the gonadotropin‐releasing hormone agonist protocol during intracytoplasmic sperm injection
by: Taketo Inoue, et al.
Published: (2018-07-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?
by: Temitope Okunola, et al.
Published: (2017-04-01)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
by: Alessandro Conforti, et al.
Published: (2021-06-01)

Semaphorin Signaling in the Development and Function of the Gonadotropin Hormone-Releasing Hormone (GnRH) System
by: Andrea eMessina, et al.
Published: (2013-09-01)